Using decision modeling to determine pricing of new pharmaceuticals: the case of neurokinin-1 receptor antagonist antiemetics for cancer chemotherapy.
Dranitsaris
George
G
Cancer Care Ontario, Toronto, Canada.
Leung
Pauline
P
D000932:Antiemetics / Q000191:economics* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003365:Costs and Cost Analysis; D003661:Decision Support Techniques; D006801:Humans; D018803:Models, Economic; D064729:Neurokinin-1 Receptor Antagonists; D019057:Quality-Adjusted Life Years; D016032:Randomized Controlled Trials as Topic; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy
D000932:Antiemetics; D000970:Antineoplastic Agents; D064729:Neurokinin-1 Receptor Antagonists